Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6ABV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $194,999
Award facts
- Contract value 100% obligated
- $194,999.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at approximately $195K for STELARA 90 MG/ML syringes from the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $500 million and valid through November 2026, which authorizes the agency to issue delivery orders for pharmaceutical items supporting Department of Defense healthcare facilities.
STELARA, a biologic immunosuppressant medication used primarily to treat autoimmune conditions, will be delivered to the Park Ridge location and distributed through the federal pharmaceutical supply chain to military health facilities. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical distribution network, leveraging its woman-owned small business status and comprehensive product portfolio to fulfill specialized medical supply requirements across the Defense Department's healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6ABV?
SPE2DX25F6ABV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 22, 2025.
How much is contract SPE2DX25F6ABV worth?
The government has obligated $194,999 on SPE2DX25F6ABV.
Is contract SPE2DX25F6ABV an order under another contract?
Yes. SPE2DX25F6ABV is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABV competed?
The extent of competition for SPE2DX25F6ABV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award